Showing 101-110 of 3104 results for "".
- Multiple Sclerosis Prevalence May Be Twice As High as Previously Thoughthttps://practicalneurology.com/news/multiple-sclerosis-prevalence-may-be-twice-as-high-as-previously-thought/2468830/A study published in the journal Neurology suggests prevalence of multiple sclerosis (MS) in the US is 913,925—more than twice the previous estimate of 400,000 people in
- FDA Recalls Software Used with Surgical Navigation Systemhttps://practicalneurology.com/news/fda-grants-breakthrough-device-designation-for-alzheimers-disease-screening-test/2468857/Medtronic has recalled software used during biopsy procedures due to reports that the products—Synergy Cranial Software and StealthStation S7 Cranial Software—provided incorrect information that could result in serious or life-threatening harm to patients. The FDA has id
- Stem-Cell Transplants Delayed Disease Progression of Multiple Sclerosishttps://practicalneurology.com/news/stem-cell-transplants-delayed-disease-progression-of-multiple-sclerosis/2468861/January 25, 2019—As published in JAMA, interim results of the phase 2 MIST trial (NCT00273364) show that stem-cell treatment resulted in a signific
- FDA Approves Generic Vigabatrin for Complex Partial Seizureshttps://practicalneurology.com/news/fda-approves-generic-vigabatrin-for-complex-partial-seizures/2468865/January 21, 2019—The Food and Drug Administration (FDA) has approved generic vigabatrin 500 mg tablets for adjunctive treatment of patients with complex partial seizures, age 10 years and older, who have not responded adequately to other treatments. “We know there has been
- New Study Will Evaluate Smart Watch Technology for Help in Preventing Strokeshttps://practicalneurology.com/news/new-study-will-evaluate-smart-watch-technology-for-help-in-preventing-strokes/2468864/January 21, 2019—A new study will analyze the impact of a smart watch (Apple, Cupertino, CA) on early detection and diagnosis of atrial fibrillation (AFib) and the potential to prevent stroke. The large-scale research will start later this year in the US and will be a pragmatic, randomized,
How to Know it When You See It: Diagnosing Neuralgic Amyotrophy (Parsonage-Turner Syndrome)
https://practicalneurology.com/diseases-diagnoses/neuromuscular/how-to-know-it-when-you-see-it-diagnosing-neuralgic-amyotrophy-parsonage-turner-syndrome/30513/An understanding of the basic science, clinical presentation, and treatment options for neuralgic amyotrophy is necessary to facilitate timely diagnosis and treatment.Botox for Chronic Migraine: Tips and Tricks
https://practicalneurology.com/diseases-diagnoses/headache-pain/botox-for-chronic-migraine-tips-and-tricks/30277/Ten Questions for Andrew M. Blumenfeld, MDAbout the Cover Artist: Purple Phoenix by Denis Ducreux, MD, PhD
https://practicalneurology.com/diseases-diagnoses/imaging-testing/about-the-cover-artist-purple-phoenix-by-denis-ducreux-md-phd/56388/Dr. Ducreux’s artwork originates in diffusion-based MRI studies that reveal the organization of white matter pathways.Expanding the Scope of Neurology: An Interview with Ralph L. Sacco, MD
https://practicalneurology.com/columns/practice-management/expanding-the-scope-of-neurology-an-interview-with-ralph-l-sacco-md/30358/New AAN President sees collaboration and wellness as integral to the future of the specialty.About the Cover Artist: Fatherhood by Bevan Choate, MD
https://practicalneurology.com/diseases-diagnoses/stroke/about-the-cover-artistifatherhoodi-by-bevan-choate-md/32198/Dr. Choate, a practicing urologist, turned to art while recovering from a stroke he experienced at age 35. He continues to use his art to advocate for those affected by brain injury.